UOC
BTMDW

UBS O'Connor’s Biote Corp. Warrant BTMDW Stock Holding History

UBS O'Connor’s Portfolio BTMDW Stock Details BTMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-62,541
Closed -$52K – 1068
2021
Q3 		$52K Hold
62,541
– – ﹤0.01% 889
2021
Q2 		$64K Buy
+62,541
New +$54.1K ﹤0.01% 857

Other funds holding BTMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

UBS O'Connor's BTMDW Position: Q4 2021 in Review

UBS O'Connor sold out of Biote Corp. Warrant (BTMDW) in Q4 2021, closing a stake of 62,541 shares — an estimated $52K sold.

UBS O'Connor first reported a position in BTMDW in Q2 2021 and held it in 2 quarters. The position peaked at $64K in Q2 2021. 49 funds tracked by Wall St. Rank hold BTMDW as of Q4 2021.

  • UBS O'Connor reported no remaining Biote Corp. Warrant position as of Q4 2021 after selling out during the quarter.
  • UBS O'Connor sold 62,541 Biote Corp. Warrant shares in Q4 2021, an estimated $52K.
  • UBS O'Connor first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 2 quarters.
  • UBS O'Connor's Biote Corp. Warrant position peaked at $64K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.